skip to content

Institute of Metabolic Science

Metabolic Research Laboratories
 

Research focus

Genomics of energy homeostasis and the cause of obesity 

Background and experience

I have double majors in Biochemistry and Computer Science.  I studied the transcriptional control of gene expression in neurons for my PhD in the Pharmacology Department at the University of Cambridge.  I joined the IMS initially as a core bioinformatician, and I moved to the COY team to work on the neuronal control of food intake. 

My have a long-term interest in genomics and genetic regulatory networks that underpin neuronal and neuroendocrine activities.  I am also a genehunter who actively looks for new genes/biology that are involved in the control of energy homeostasis. 

Working at the IMS-MRL

I work closely with Prof Giles Yeo and Dr John Tadross in mapping the appetitive centres of the brain in both mice and humans using modern single-cell sequencing and spatial transcriptomics.  We recently published the hypothalamic single-cell atlas of the mouse (HypoMAP) and we are currently building the human equivalent. 

I have also been working with Prof. Sir Steve O’Rahilly on large-scale genetic screens in study cohorts such as Fenland and ALSPAC, and more recently the UK Biobank with Prof. John Perry, to look for rare, protein-altering variants in metabolic genes.  We perform biochemical characterisation in experimental models and statistical genetic tests to study their effects on metabolic health in humans. 

Awards

Co-recipient of the IMS Director’s Collaborative Award 2022 –with Drs Ionel Sandovici and Ben Jenkins 

Society for Endocrinology Early Career Grant 2017 

Co-workers and collaborators 

Prof Ken Ong 

Publications

Key publications: 
  • Steuernagel, L., Lam, B.Y.H., Klemm, P. et al. HypoMap—a unified single-cell gene expression atlas of the murine hypothalamus. Nat Metab 4, 1402–1419 (2022). https://doi.org/10.1038/s42255-022-00657-y *co-first author 

  • Wade, K.H., Lam, B.Y.H., Melvin, A. et al. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort. Nat Med 27, 1088–1096 (2021). https://doi.org/10.1038/s41591-021-01349-y *co-first author 

Senior Research Associate
Coll, O'Rahilly & Yeo Groups

Contact Details

Email address: